ArticleInternational journal of molecular sciences2023
Development of Novel Class of Phenylpyrazolo[3,4-
Ahmed K B Aljohani, Waheed Ali Zaki El Zaloa, Mohamed Alswah, Mohamed A Seleem, Mohamed M Elsebaei, Ashraf H Bayoumi, Ahmed M El-Morsy, Mohammed Almaghrabi, Aeshah A Awaji, Ali Hammad and 2 more
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Ahmed K B AljohaniPharmacognosy and Pharmaceutical Chemistry Department, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 41477, Saudi Arabia.
Waheed Ali Zaki El ZaloaPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.
Mohamed AlswahPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.ORCID 0000-0002-4328-2963 Mohamed A SeleemPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.ORCID 0000-0003-4379-5133 Mohamed M ElsebaeiPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.ORCID 0000-0002-0890-7219 Ashraf H BayoumiPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.
Ahmed M El-MorsyPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.ORCID 0000-0003-1549-7673 Mohammed AlmaghrabiPharmacognosy and Pharmaceutical Chemistry Department, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 41477, Saudi Arabia.ORCID 0000-0003-4929-7071 Aeshah A AwajiDepartment of Biology, Faculty of Science, University College of Taymaa, University of Tabuk, Tabuk 71491, Saudi Arabia.
Ali HammadPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.
Marwa AlsulaimanyPharmacognosy and Pharmaceutical Chemistry Department, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 41477, Saudi Arabia.ORCID 0009-0001-0208-2658 Hany E A AhmedPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.
Funding
Taibah University 445-9-238
6 · The paper itselfAbstract
Indexed as
Antineoplastic AgentsLung NeoplasmsAntimetabolitesCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorErbB ReceptorsHumansMolecular Docking SimulationMolecular StructureMutationProtein Kinase InhibitorsPyrimidinesStructure-Activity RelationshipAntimetabolitesAntineoplastic AgentsErbB ReceptorsProtein Kinase InhibitorsPyrimidinesapoptosiscell cycle analysisdockingEGFRphenylpyrazolo[3,4-d]pyrimidinetyrosine kinaseVGFR
Identifiers
PMID37834474
PMCPMC10573254
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390